Human immunoglobulin preparations for intravenous or subcutaneous administration are
the cornerstone of treatment in patients with primary immunodeficiency diseases affecting …

Human immunoglobulin prepared for intravenous administration (IGIV) has a number of
important uses in the treatment of disease. Some of these are in diseases for which …

Clinical uses of intravenous immunoglobulin | Clinical and Experimental Immunology | Oxford
Academic Skip to Main Content Advertisement intended for healthcare professionals Oxford …

Background Different therapeutic strategies are available for treatment of multiple sclerosis
(MS) including immunosuppressants, immunomodulators, and monoclonal antibodies. Their …

Relapses, exacerbations or attacks of multiple sclerosis are the dominating feature of
relapsing‐remitting multiple sclerosis (MS), but are also observed in patients with secondary …

Cellular blood components and plasma-derived medicinal products (PDMPs) are obtained
from blood donated by volunteers. In a growing number of countries, in line with World …

Acute and subacute inflammation, the mechanisms by which demyelination and axonal loss
occur in multiple sclerosis (MS), result from the migration of activated immune cells into the …

Therapeutic approaches for autoimmune diseases are primarily based on suppressive
measures that down regulate an over productive immune system. The increasing availability …

Intravenous immunoglobulin (IVIG) use in non-approved indications, the increase in
consumption and its high cost recommend rationalisation in its utilisation. Aims To assess …

Treatment of multiple sclerosis has changed dramatically over the past decade. Enhanced
understanding of the immunopathological processes that underlie the disease, advances in …